Citation: Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, et al. A randomised, blinded, placebo-controlled trial in dementia sufferers continuing or stopping neuroleptics . PLoS Med 5: e76.. A randomised, blinded, placebo-controlled trial in dementia individuals stopping or continuing neuroleptics Results of a randomised trial published in PLoS Medication show no benefit in cognitive or neuropsychiatric outcomes from continuing neuroleptic medications in patients with Alzheimer's disease. The researchers, led by Clive Ballard from King's College medical center, London, recruited 165 sufferers from across the UK who were becoming treated with neuroleptic drugs already. They randomised fifty % of the patients to keep treatment and half to discontinue treatment.He speaks from encounter. Dr. Servan-Schreiber managed to extend his existence for 19 years, living as he do with an inoperable brain tumor. He describes several approaches to managing cancers as a chronic condition in his publication, approaches such as enhancing the immune system, ingesting foods and spices known to fight cancer, reducing irritation and becoming balanced in body, mind and spirit. In the written publication Radical Remission, Dr. Kelly Turner, PhD, describes her quest to discover what exactly allowed people, some with advanced cancers seriously, to achieve a comprehensive remission.